Follow
Nicole Berndt
Nicole Berndt
Verified email at hzdr.de
Title
Cited by
Cited by
Year
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity
C Günther, B Kind, MAM Reijns, N Berndt, M Martinez-Bueno, C Wolf, ...
The Journal of clinical investigation 125 (1), 413-424, 2015
2102015
PET/MRI in head and neck cancer: initial experience
I Platzek, B Beuthien-Baumann, M Schneider, V Gudziol, J Langner, ...
European journal of nuclear medicine and molecular imaging 40, 6-11, 2013
162*2013
RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA
C Wolf, A Rapp, N Berndt, W Staroske, M Schuster, M Dobrick-Mattheuer, ...
Nature communications 7 (1), 11752, 2016
1532016
Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system
C Arndt, A Feldmann, M Von Bonin, M Cartellieri, EM Ewen, S Koristka, ...
Leukemia 28 (1), 59-69, 2014
882014
“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells
N Mitwasi, A Feldmann, C Arndt, S Koristka, N Berndt, J Jureczek, ...
Scientific reports 10 (1), 2141, 2020
752020
From mono-to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
S Albert, C Arndt, S Koristka, N Berndt, R Bergmann, A Feldmann, ...
Oncotarget 9 (39), 25597, 2018
632018
Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3′ repair exonuclease 1 (TREX1)
C Günther, N Berndt, C Wolf, MA Lee-Kirsch
JAMA dermatology 151 (4), 426-431, 2015
592015
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
R Aliperta, PB Welzel, R Bergmann, U Freudenberg, N Berndt, ...
Scientific reports 7 (1), 42855, 2017
582017
Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma
C Günther, N Zimmermann, N Berndt, M Großer, A Stein, A Koch, ...
The American journal of pathology 179 (3), 1434-1442, 2011
572011
Deregulated type I IFN response in TREX1-associated familial chilblain lupus
K Peschke, F Friebe, N Zimmermann, T Wahlicht, T Schumann, ...
The Journal of investigative dermatology 134 (5), 1456, 2014
532014
Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
LR Loureiro, A Feldmann, R Bergmann, S Koristka, N Berndt, C Arndt, ...
Blood cancer journal 8 (9), 81, 2018
462018
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy
A Feldmann, A Hoffmann, R Bergmann, S Koristka, N Berndt, C Arndt, ...
Oncoimmunology 9 (1), 1785608, 2020
442020
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
N Mitwasi, A Feldmann, R Bergmann, N Berndt, C Arndt, S Koristka, ...
Oncotarget 8 (65), 108584, 2017
442017
Comparison of the stability of Y-90-, Lu-177-and Ga-68-labeled human serum albumin microspheres (DOTA-HSAM)
G Wunderlich, E Schiller, R Bergmann, HJ Pietzsch
Nuclear medicine and biology 37 (8), 861-867, 2010
422010
Conventional CARs versus modular CARs
A Feldmann, C Arndt, S Koristka, N Berndt, R Bergmann, MP Bachmann
Cancer Immunology, Immunotherapy 68, 1713-1719, 2019
412019
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells
C Arndt, LR Loureiro, A Feldmann, J Jureczek, R Bergmann, D Máthé, ...
Oncoimmunology 9 (1), 1743036, 2020
322020
Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers
LR Loureiro, A Feldmann, R Bergmann, S Koristka, N Berndt, D Máthé, ...
Journal of Experimental & Clinical Cancer Research 39, 1-13, 2020
272020
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
C Arndt, A Feldmann, S Koristka, M Schäfer, R Bergmann, N Mitwasi, ...
Oncoimmunology 8 (11), 1659095, 2019
262019
SMARCAD1 haploinsufficiency underlies Huriez syndrome and associated skin cancer susceptibility
C Günther, MA Lee-Kirsch, J Eckhard, A Matanovic, T Kerscher, ...
The Journal of investigative dermatology 138 (6), 1428-1431, 2018
262018
Improved conjugation, 64-cu radiolabeling, in vivo stability, and imaging using nonprotected Bifunctional macrocyclic ligands: Bis (Phosphinate) Cyclam (BPC) Chelators
T David, V Hlinová, V Kubicek, R Bergmann, F Striese, N Berndt, ...
Journal of Medicinal Chemistry 61 (19), 8774-8796, 2018
252018
The system can't perform the operation now. Try again later.
Articles 1–20